-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$0.50354.55% Upside
CNS Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover CNS Pharmaceuticals, Inc.?
CNS Pharmaceuticals, Inc. has been rated by research analysts at Maxim Group in the past 90 days.